These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23023846)

  • 1. Self-assessment tool for screening patients at risk for drug therapy problems.
    Rovers J; Hagel H
    J Am Pharm Assoc (2003); 2012; 52(5):646-52. PubMed ID: 23023846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Community Pharmacy-Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems.
    Pammett RT; Blackburn D; Taylor J; Mansell K; Kwan D; Papoushek C; Jorgenson D
    Pharmacotherapy; 2015 Sep; 35(9):881-6. PubMed ID: 26406776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying patients at risk of cardiovascular disease: a pharmacist-managed screening event for union workers and their dependents.
    Liu Y; McDonough RP; Carruthers KM; Doucette WR
    J Am Pharm Assoc (2003); 2009; 49(4):549-53. PubMed ID: 19589768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
    Breslow RM
    J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents.
    Liu Y; Mentele LJ; McDonough RP; Carruthers KM; Doucette WR
    J Am Pharm Assoc (2003); 2008; 48(4):515-7. PubMed ID: 18653428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting health communication between the community-dwelling well-elderly and pharmacists: the Ask Me 3 program.
    Miller MJ; Abrams MA; McClintock B; Cantrell MA; Dossett CD; McCleeary EM; McGee MJ; O'Keefe KJ; Sager ER
    J Am Pharm Assoc (2003); 2008; 48(6):784-92. PubMed ID: 19019809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.
    Rosser S; Frede S; Conrad WF; Heaton PC
    J Am Pharm Assoc (2003); 2013; 53(1):22-9. PubMed ID: 23636152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of a community pharmacy-based rural asthma management service.
    Saini B; Filipovska J; Bosnic-Anticevich S; Taylor S; Krass I; Armour C
    Aust J Rural Health; 2008 Apr; 16(2):100-8. PubMed ID: 18318852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting.
    Winfrey C; Wortman S; Frede S; Kunze N; Conrad WF; Heaton PC
    J Am Pharm Assoc (2003); 2011; 51(3):373-7. PubMed ID: 21555289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate.
    Luder HR; Frede SM; Kirby JA; Epplen K; Cavanaugh T; Martin-Boone JE; Conrad WF; Kuhlmann D; Heaton PC
    J Am Pharm Assoc (2003); 2015; 55(3):246-54. PubMed ID: 26003155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression screenings: developing a model for use in a community pharmacy.
    Hare SK; Kraenow K
    J Am Pharm Assoc (2003); 2008; 48(1):46-51. PubMed ID: 18192130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of wellness coaching and monitoring services provided in a community pharmacy.
    DiDonato KL; May JR; Lindsey CC
    J Am Pharm Assoc (2003); 2013; 53(1):14-21. PubMed ID: 23636151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
    Emmerton L
    J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A feasibility study of community pharmacists performing depression screening services.
    O'Reilly CL; Wong E; Chen TF
    Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported responses to medication therapy management services for older adults: analysis of a 5-year program.
    Cook DM; Moulton PV; Sacks TM; Yang W
    Res Social Adm Pharm; 2012; 8(3):217-27. PubMed ID: 21955807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
    Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
    Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacist-led community bone mineral density screenings.
    Summers KM; Brock TP
    Ann Pharmacother; 2005 Feb; 39(2):243-8. PubMed ID: 15613465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle changes for prehypertension with other cardiovascular risk factors: findings from Thailand.
    Pongwecharak J; Treeranurat T
    J Am Pharm Assoc (2003); 2011; 51(6):719-26. PubMed ID: 22068193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.